Trader @UnshackledTrade Notes Bulenox Sim Loss Amid TradeDay Payout

On October 26, X user @UnshackledTrade posted a monthly recap documenting fifteen Bulenox evaluation purchases, five passes and ten failures, alongside a four thousand dollar payout taken from a separate firm, TradeDay, the prior week.

On Monday, October 26, the trader @UnshackledTrade posted on X a candid monthly accounting that referenced Bulenox alongside other prop firms. The post states that his Bulenox sim accounts were lost again after a rough stretch of shorting morning rallies in the index futures, and that he had purchased fifteen Bulenox evaluations during the month, passing five and failing ten, with plans to activate the passed accounts that evening.

The documented payout in the same post was not from Bulenox. The trader reports a four thousand dollar payout taken from TradeDay the prior week, netting roughly thirty two hundred dollars after the firm's split, and a second four thousand dollar request submitted the day of the post. No Bulenox payout is claimed or shown. The proof here is a firm-stated activity log on Bulenox evaluations, not a receipt of funds from Bulenox itself.

“I bought 15 bulenox evals, passed 5, failed 10, and I will active them again this evening.”— @UnshackledTrade on X, October 26

The post identifies the Nasdaq futures and the micro Nasdaq, tagged as NQ and MNQ, as the instruments in play, and references a daily loss limit breach on his Bulenox and FundingNext sim accounts. It does not disclose the Bulenox account size, the specific evaluation tier purchased, or the strategy beyond short attempts into morning strength. Readers should treat those details as unestablished by this proof.

Monthly spend on evaluations was running at forty five hundred dollars at the time of posting, which the trader frames against the TradeDay payouts as the path to finishing October roughly flat. He also notes that October 2025 ended down sixteen thousand dollars net for him, context that frames this month as a recovery attempt rather than a winning run. The honest tone, including a ten of fifteen failure rate on Bulenox evaluations, is itself the signal worth recording.